Reference values for quality control of in vitro susceptibility tests with cefotetan against anaerobic bacteria were determined in two independent multilaboratory studies with the approved National Committee for Clinical Laboratory Standards agar dilution method and three control strains (Bacteroides fragilis ATCC 25285, Bacteroides thetaiotaomicron ATCC 29741, and Clostridium perfringens ATCC 13124). The Cefotetan is a long-acting cephamycin recommended for use in mixed aerobic and anaerobic intra-abdominal and pelvic infections (1, 6). Cefotetan reference values for quality control of in vitro susceptibility tests against bacteria that grow aerobically have been established (2).
Cefotetan is a long-acting cephamycin recommended for use in mixed aerobic and anaerobic intra-abdominal and pelvic infections (1, 6) . Cefotetan reference values for quality control of in vitro susceptibility tests against bacteria that grow aerobically have been established (2) .
To provide clinical microbiologists with cefotetan MIC quality control guidelines for use in anaerobic susceptibility testing, two independent, multilaboratory studies were conducted. The first study (study A) satisfied the requirements outlined by the National Committee for Clinical Laboratory Standards (NCCLS) (4 of the study. Cefoxitin was tested by all laboratories to provide a procedural control. The two Bacteroides species provided cefoxitin endpoints that were within the control limits defined by the NCCLS (3). However, two laboratories (study A) reported cefoxitin MICs for the C. perfringens isolate that were 1 dilution greater than the accepted upper limit of 1.0 1tg/ml. a Determined in two independent multicenter studies by using Wilkins-Chalgren agar without added blood or other supplements.
b Study A, A five-laboratory coordinated study which fulfills the requirements of the NCCLS (4); study B, an extended study contributing additional MICs from two other facilities.
inconsistencies in results when this reference organism was tested against other P-lactam antibiotics (8) .
Study B participants also performed tests with WilkinsChalgren agar containing 5% sheep blood. With the added blood, cefotetan MICs for the two Bacteroides species fell within the MIC control ranges that are recommended herein (data not shown). Even with added blood, results for C. perfringens ATCC 13124 were too erratic to provide useful control information. If the addition of sheep blood is re- quired for growth of the organism being tested, the activity of cefotetan will probably not be affected.
It is possible that the inconsistency of results observed with C. perfringens ATCC 13124 is related to difficulties in obtaining a standardized inoculum due to the cellular morphology or growth characteristics of the organism (7) or to difficult-to-interpret endpoints (8) or both. These possibilities are currently under investigation in our laboratories. Alternative control strains should be considered in the near future.
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